Navigation Links
Drug blocks two of world's deadliest emerging viruses
Date:3/5/2009

NEW YORK (March 5, 2009) -- Two highly lethal viruses that have emerged in recent outbreaks are susceptible to chloroquine, an established drug used to prevent and treat malaria, according to a new basic science study by researchers at Weill Cornell Medical College in the Journal of Virology. Due to the study's significance, a manuscript was published yesterday online, in advance of the print issue, and will be highlighted as an editor's "spotlight" in the first May issue.

The two henipaviruses that are the subject of the study -- Hendra Virus (HeV) and Nipah Virus (NiV) -- emerged during the 1990s in Australia and Southeast Asia. Harbored by fruit bats, they cause potentially fatal encephalitis and respiratory disease in humans, with a devastating 75 percent fatality rate. More recently, NiV outbreaks in Bangladesh involving human-to-human transmission have focused attention on NiV as a global health concern.

The researchers, based in Weill Cornell's pediatrics department, were surprised by their discovery that chloroquine, a safe, low-cost agent that has been used to combat malaria for more than 50 years, is a highly active inhibitor of infection by Hendra and Nipah.

"The fact that chloroquine is safe and widely used in humans means that it may bypass the usual barriers associated with drug development and move quickly into clinical trials," says Dr. Anne Moscona, professor of pediatrics and microbiology & immunology at Weill Cornell Medical College and senior author of the study. She is also vice chair for research of pediatrics at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

"Chloroquine stands a good chance of making it through the development process in time to prevent further outbreaks of these deadly infections," adds Dr. Moscona.

Like the avian flu, SARS, and Ebola viruses, Hendra and Nipah are zoonotic pathogens. That means they originate in certain animals but can jump between
'/>"/>

Contact: Andrew Klein
ank2017@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Drug blocks 2 of worlds deadliest emerging viruses
2. NLRB Blocks New Organizations Attempts to Divide UHW; SEIU UHW Committed to Securing Good Contracts With Members
3. Beta Blocker Blocks Feelings of Bad Memories
4. USC study finds that green tea blocks benefits of cancer drug
5. Jefferson researchers show antibody to breast cancer-secreted protein blocks metastasis
6. Experimental agent blocks prostate cancer in animal study
7. C5 Medical Werks Applies for Clearance, Certification and Licensing for the Global Marketing of ZirDent(TM) Ceramic CAD/CAM Dental Blocks
8. Monkey Gene That Blocks AIDS Viruses Evolved More Than Once
9. Iowa State chemists track how drug changes, blocks flu virus
10. Super-Thin Drug-Free Coating Hides Stent as It Unblocks Heart Arteries
11. Grape powder blocks genes linked to colon cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... On Sunday, June 7, 2015, tens of ... their local communities to observe the 28th annual National ... and abroad will hold celebrations on this day to ... challenges of cancer survivorship, and to show the world ... rewarding, and inspiring.,  , National Cancer Survivors Day® is ...
(Date:6/3/2015)... are challenging and unpredictable times for traditional organizations across ... are rewriting the rules for business as we knew ... businesses to take on a more agile approach in ... On top of this there is a growing trend ... new innovation and approaches to business. , The manager ...
(Date:6/3/2015)... ON (PRWEB) June 03, 2015 On ... a Marketing Authorization (MA), effective immediately, which now permits ... foods that contain oats as ingredients. The MA is ... being developed. All stakeholders should be aware that, unlike ... in the USA, there are restrictions for gluten-free oat ...
(Date:6/3/2015)... Veatch Consulting Services is excited to ... opened for business in April 2006, they have made ... their clients. Each and every year they have worked ... proud to say that they are off to a ... recently added this year is the Customer Review site ...
(Date:6/2/2015)... BALTIMORE, Md. – Ellarea Maria ... about wellness after being diagnosed with lupus. In spite ... lifestyle changes which enhance health, lupus and other autoimmune ... Wellspring for Wellness ,” she offers a holistic approach ... book provides an overview of some autoimmune diseases—especially ...
Breaking Medicine News(10 mins):Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 2Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 3Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 4Health News:Chief Digital Officer of Travelex joins Bayer, Abellio and Just Eat at The Open Mobile Summit London 2Health News:Health Canada Allows For Conditional Use Of Gluten-Free Oats 2Health News:Health Canada Allows For Conditional Use Of Gluten-Free Oats 3Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 2Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 3Health News:New book offers holistic approach in living with autoimmune diseases 2Health News:New book offers holistic approach in living with autoimmune diseases 3
... By Amanda Gardner HealthDay Reporter , THURSDAY, March ... that screening for prostate cancer does not substantially reduce the ... hand, a good many men might receive false-positive results and ... researchers report in the March 31 online issue of the ...
... A potential new experimental diagnostic test able to quickly ... latent TB infection has been developed. If the preliminary ... larger population sample, the new diagnostic system could allow ... re-emerging pathology. The work was performed by ...
... system to perform in vivo RNAi screens for ... hepatocyte proliferation during chronic liver damage.1 Functional ... of the candidate gene by different shRNAs can ... and also increase the regenerative capacity of chronically ...
... new TNM 7 lung cancer staging system seems to ... of lung cancer following surgery, according to a study ... of Thoracic Oncology . Being able to better ... important, especially given the controversies surrounding the use of ...
... target for lung cancer has been discovered by researchers at ... the protein AIMP2 is highly expressed in lung cancer cells ... show lower survival. The study is published on March 31 ... Lung cancer is one of the world,s most common cancers ...
... leading cancer organizations shows rates of death in the United States ... 2003 and 2007. The findings come from the latest Annual Report ... report also finds that the overall rate of new cancer diagnoses ... than 1 percent per year for the same period. Edward ...
Cached Medicine News:Health News:Prostate Cancer Screening Doesn't Cut Death Rates: Study 2Health News:Prostate Cancer Screening Doesn't Cut Death Rates: Study 3Health News:A new experimental diagnostic test able to quickly distinguish infection from tuberculosis disease 2Health News:A new experimental diagnostic test able to quickly distinguish infection from tuberculosis disease 3
(Date:6/3/2015)... 2015 The treatment pipeline for ... says  GBI Research . ... Acute Myeloid Leukemia Therapeutics Market to 2020 - forecasts ... moderately from $632.6 million in 2013 to $878.6 million by ... Several drugs to treat AML are expected to ...
(Date:6/3/2015)... SHANGHAI , June 3, 2015 MEDTEC China South ... an extension of MEDTEC China 2015, MEDTEC China South has ... attributes, standing out as a key event for the medical ... After many years of challenges, this year marks the successful return ... 10 years after the event first debuted there in 2005. ...
(Date:6/3/2015)... 2015  Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), ... its expertise in opioid antagonists, announced today that ... opioid overdose with intranasal naloxone, has commenced a ... to the United States Food and Drug Administration ... a drug intended to treat opioid overdose.  A ...
Breaking Medicine Technology:Novel Acute Myeloid Leukemia Therapies to Offer Clinical Benefit in Small Patient Cohorts 2Novel Acute Myeloid Leukemia Therapies to Offer Clinical Benefit in Small Patient Cohorts 3MEDTEC Successfully Returns to Southern China 2MEDTEC Successfully Returns to Southern China 3Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxone 2Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxone 3
... MUNDELEIN, Ill. , July 20 ... and information systems technology, today announced the addition of ... Sysmex hematology product offering.  The DM1200 enables Sysmex America ... analysis, which improves both the quality of results and ...
... Mich. , July 20 Two southeast Michigan ... in the region.  Delphinus Medical Technologies and Quantum Signal were approved today for ... of Michigan . , , , ... Arbor region continues to be a magnet for growing, high tech companies," ...
Cached Medicine Technology:Sysmex America Begins Distribution of CellaVision® DM1200 2Sysmex America Begins Distribution of CellaVision® DM1200 3Quantum Signal and Delphinus Medical Technologies Awarded MEGA Funding to Expand in Ann Arbor Area 2Quantum Signal and Delphinus Medical Technologies Awarded MEGA Funding to Expand in Ann Arbor Area 3
... With the GE Innova 2100IQ: See the ... legs. Place interventional devices. Its all enabled ... panel that helps deliver excellent image quality ... Innova family systems installed worldwide, more physicians ...
... provides clinically valuable, device-derived information applicable ... to help specialty physicians discern if ... stable or deteriorating. For example, heart ... Medtronic InSync Sentry™ CRT-D system can ...
... (ALS) is a GH dependent protein which is ... acid peptide with a predicted molecular weight of ... confined to a ~150 KDa GH-dependent ternary protein ... or IGF-II, and this unique acid-labile subunit (ALS) ...
... was first identified in 1980 (1) and has ... of appetite (2). PYY is produced by the ... intake, and is found to decrease appetite. The ... the circulation is PYY3-36, the N-terminal truncated form ...
Medicine Products: